Chemicals, pharma represent project opportunities as capex cuts escalate: analyst

Chemicals, pharma represent project opportunities as capex cuts escalate: analyst

Hit hard by the COVID-19 pandemic and the volatile price of oil, project owners have cut their capex spending plans by $154 billion, according to research firm Independent Project Analysis.

Please log in below to view the rest of this page. If you do not have an account, please register or subscribe below for access.